guest ::
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
; ; ; ; ; ; ; ; ; ; ; ;
In
Biological and Clinical Implications of the Mutational Landscape in Myeloproliferative Neoplasms
In
Frontiers in oncology 13, Seiten/Artikel-Nr.:1277453
2023
Online
DOI: 10.18154/RWTH-CONV-252232
DOI: 10.3389/fonc.2023.1277453
URL: https://publications.rwth-aachen.de/record/982169/files/982169.pdf
Einrichtungen
OpenAccess: 
PDF
Dokumenttyp
Journal Article/Contribution to a book
Format
online
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85175806708
WOS Core Collection: WOS:001170573400001
PubMed: pmid:37941547
Interne Identnummern
RWTH-CONV-252232
Datensatz-ID: 982169
Beteiligte Länder
Germany
; 
; 
; 
; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF